Significant target organs for hypertension and cardiac hypertrophy by angiotensin-converting enzyme inhibitors

Hypertension Research

Volumn 27, Issue 3, 2004, Pages 213-219

  Takai, Shinji ^a   Jin, Denan ^a   Sakaguchi, Masato ^a   Miyazaki, Mizuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Angiotensin II; Angiotensin converting enzyme; Blood pressure; Cardiac hypertrophy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; PERINDOPRIL; TEMOCAPRIL; TRANDOLAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; AORTA; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG TISSUE LEVEL; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HYPERTENSION; KIDNEY; MALE; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STATISTICAL SIGNIFICANCE; TARGET ORGAN; VASCULAR TISSUE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; BRAIN; CARDIOMEGALY; HYPERTENSION; KIDNEY; MALE; MYOCARDIUM; ORGAN SIZE; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, INBRED SHR; TIME FACTORS;

EID: 1842867025     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.27.213     Document Type: Article

References (24)

1. Okunishi H, Kawamoto T, Kurobe Y, et al: Pathogenetic role of vascular angiotensin-converting enzyme in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 1991; 18: 649-659.
2. Morishita R, Higaki J, Okunishi H, et al: Effect of long-term treatment with an angiotensin-converting enzyme inhibitor on the renin-angiotensin system in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1991; 18: 685-690.
3. Shiota N, Miyazaki M, Okunishi H: Increase of angiotensin converting enzyme gene expression in the hypertensive aorta. Hypertension 1992; 20: 168-174.
4. Okunishi H, Kawamoto T, Kobayashi T, Sakonjo H, Miyazaki M: Prolonged and tissue selective inhibition of vascular angiotensin-converting enzyme by trandolapril: relevance to its antihypertensive action in spontaneously hypertensive rats. Pharm Pharmacol Lett 1992; 2: 180-183.
5. Ablonskis LT, Rogers PF, Lungershausen YK, Howe PR: Chronic central administration of enalaprilat lowers blood pressure in stroke-prone spontaneously hypertensive rats. J Auton Nerv Syst 1992; 39: 119-126.
6. Takai S, Song K, Tanaka T, Okunishi H, Miyazaki M: Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice. Life Sci 1996; 59: PL331-PL336.
7. Takai S, Sakonjo H, Miyazaki M: Beneficial effect of trandolapril on the lifespan of a severe hypertensive model. Hypertens Res 2001; 24: 559-564.
8. Miyazaki M, Okunishi H, Okamura T, Toda N: Elevated vascular angiotensin converting enzyme in chronic two-kidney, one clip hypertension in the dog. J Hypertens 1987; 5: 155-160.
9. Jin D, Takai S, Shiota N, Miyazaki M: Roles of vascular angiotensin converting enzyme and chymase in two-kidney, one clip hypertensive hamsters. J Hypertens 1998; 16: 657-664.
10. Vicaut E, Hou X: Duration of inhibition of local microvascular ACE in spontaneously hypertensive rats. J Hypertens 1995; 13: 1758-1763.
11. Moursi MG, Ganten D, Lang RE, Unger T: Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats. J Hypertens 1986; 4 (Suppl): S495-S498.
12. Gohlke P, Scholkens B, Henning R, Urbach H, Unger T: Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and Hoe 288. J Cardiovasc Pharmacol 1989; 14 (Suppl 4): S32-S36.
13. Raasch W, Dendorfer A, Ball B, Dominiak P: The lipophilic properties of angiotensin I-converting enzyme inhibitors do not influence their diffusion through cultured endothelium. Jpn J Pharmacol 1999; 81: 346-352.
14. Shionoiri H, Takasaki I, Minamisawa K, et al: Trandolaprilat, an angiotensin-converting enzyme inhibitor, is not excreted in bile via an ATP-dependent active transporter (cMOAT). Hypertens Res 2001; 24: 235-240.
15. Ishizuka H, Konno K, Naganuma H, et al: Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR). J Pharmacol Exp Ther 1997; 280: 1304-1311.
16. Chiba K, Moriyama S, Ishigai Y, Fukuzawa A, Irie K, Shibano T: Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery. Br J Pharmacol 1994; 112: 837-842.
17. Wang DQ, Kakizoe E, Kobayashi Y, Shimoura K, Okunishi H: Differential suppression of pressure-overload cardiac and aortic hypertrophy in rats by angiotensin-converting enzyme inhibitors. Jpn J Pharmacol 1999; 80: 333-342.
18. Childs TJ, Adams MA, Mak AS: Regression of cardiac hypertrophy in spontaneously hypertensive rats by enalapril and the expression of contractile proteins. Hypertension 1990; 16: 662-668.
19. Nagano M, Higaki J, Mikami H, et al: Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats. J Hypertens 1991; 9: 595-599.
20. Tamura T, Said S, Harris J, Lu W, Gerdes AM: Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system. Circulation 2000; 102: 253-259.
21. Oda T, Iijima Y, Sada T, Nishino H, Oizumi K, Koike H: Effects of chronic treatment with a novel angiotensin converting enzyme inhibitor, CS622, and a vasodilator, hydralazine, on atrial natriuretic factor (ANF) in spontaneously hypertensive rats (SHR). Biochem Biophys Res Commun 1988; 152: 456-462.
22. Thibault G, Arguin C, Garcia R: Cardiac endothelin-1 content and receptor subtype in spontaneously hypertensive rats. J Mol Cell Cardiol 1995; 27: 2327-2336.
23. Kim S, Zhan Y, Izumi Y, Iwao H: Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats. Hypertension 2000; 35: 769-774.
24. Kinoshita A, Urata H, Bumpus FM, Husain A: Measurement of angiotensin I converting enzyme inhibition in the heart. Circ Res 1993; 73: 51-60.